Onconetix, Inc. Form 8-K Summary
Business Context and Reporting Period
Onconetix, Inc. (ONCO), a Delaware corporation, filed this Current Report on Form 8-K on July 29, 2026, regarding events occurring on July 28, 2026. The company is an emerging growth company with its principal executive offices in Cincinnati, Ohio. The filing details the entry into material definitive agreements to secure capital through a Private Investment in Public Equity (PIPE) transaction and the establishment of an equity line of credit (ELOC).
Key Financial Metrics and Capital Structure
- PIPE Financing: The Company agreed to issue and sell 37,812 shares of Series F Convertible Preferred Stock to an accredited investor for an aggregate purchase price of $30,249,600.
- Series F Preferred Stock Terms:
- Stated Value: $1,000 per share.
- Initial Conversion Price: $0.9767 per share of Common Stock.
- Dividends: Payable when declared; Default Dividends accrue at 15.0% per annum upon a Triggering Event.
- Ranking: Senior to Common Stock; pari passu with Series C, D, and E Preferred Stock.
- Equity Line of Credit (ELOC):
- Committed Facility: Up to $750,000,000 or 19.99% of outstanding Common Stock (whichever is less).
- Commitment Fee: $30,000,000 paid to the ELOC Investor, which was applied toward the purchase of the Series F Preferred Stock.
- Liquidity and Cash Flow: The filing does not provide specific cash balance, operating cash flow, or debt figures. The transactions are designed to provide immediate capital ($30.25M) and future liquidity access (up to $750M).
Material Changes and Agreements
The primary material change is the execution of two significant financing agreements on July 28, 2026:
- Securities Purchase Agreement: Issuance of Series F Preferred Stock. The Company must reserve 150% of the shares necessary for conversion. Holders have alternate conversion rights upon Triggering Events (e.g., failure to file registration statements, bankruptcy, suspension of trading).
- ELOC Purchase Agreement: Establishment of an at-the-market equity facility. The Company controls the timing and amount of sales. The ELOC Investor has no obligation to purchase shares unless directed by the Company.
Guidance, Risks, and Contingencies
- Registration Rights: The Company must file a registration statement for the PIPE shares within 45 days and have it declared effective within 90 days (or 120 days if reviewed). Failure to do so triggers a penalty of 1% of the purchase price per 30-day period.
- Ownership Limitations: Holders cannot convert shares if it results in beneficial ownership exceeding 4.99% (expandable to 9.99% with notice). The ELOC is capped at 19.99% of outstanding shares unless stockholder approval is obtained.
- Redemption Rights: The Company has the right to redeem Series F Preferred Stock at 125% of the greater of the Conversion Amount or a value based on the highest closing sale price during a measurement period.
- Risks: The filing notes that the securities were sold unregistered under Section 4(a)(2) and Rule 506. The ELOC is subject to termination by the Company with one trading day's notice or by the Investor with ten trading days' notice upon specified events.
Investor Verification Checklist
- Verify the effectiveness of the registration statement for the Series F Preferred Stock conversion shares within the 90-day window to avoid penalty payments.
- Confirm the Company's current cash position and burn rate to assess the necessity of utilizing the $750M ELOC facility.
- Review the "Triggering Events" in the Certificate of Designations to understand conditions that could accelerate conversion or increase dividend obligations.
- Check for any pending stockholder approval requirements regarding the 19.99% ELOC cap under Nasdaq listing rules.
- Monitor the Company's ability to maintain the 150% share reserve requirement for the Series F Preferred Stock.